Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | KDM5C | P41229 | 1/20 | 0.43 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL963479 | 0.88 | CTSD (0.45) | CTSDKDM4EKDM5CPHF8KDM2A | |
| SCHEMBL963046 | 0.79 | CTSD (0.50) | CTSDKDM4EKDM5CPHF8KDM2A | |
| SCHEMBL6037110 | 0.78 | TSHR (0.40) | ALDH1A1LMNAPOLBCYP3A4CYP2C19 | |
| SCHEMBL964969 | 0.77 | CTSD (0.41) | CTSDKDM4EKDM5CPHF8KDM2A | |
| SCHEMBL3463747 | 0.75 | TSHR (0.32) | ALDH1A1HTTCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL121146 | 0.75 | TSHR (0.57) | KDM4EGAAALDH1A1LMNAMAPT | |
| SCHEMBL12190502 | 0.72 | PAOX (0.50) | KDM4EGAALMNAPOLBTSHR | |
| SCHEMBL909260 | 0.72 | TSHR (0.41) | KDM5CPHF8KDM2AALDH1A1LMNA | |
| SCHEMBL11049399 | 0.72 | ALDH1A1 (0.45) | KDM4EGAAALDH1A1LMNAMAPT | |
| SCHEMBL28057030 | 0.71 | CTSD (0.46) | CTSDKDM4EKDM5CPHF8KDM2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3074415-A1 | NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES | Agency For Science, Technology And Research (SG) | 2016-10-05 | — | — | EP | claimed |
| WO-2015080670-A1 | NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-06-04 | — | — | WO | claimed |
| US-20070161043-A1 | Methods of Preparing Multicolor Quantum Dot Tagged Beads and Conjugates Thereof | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 2007-07-12 | — | — | US | claimed |
| EP-1410031-A2 | METHODS OF PREPARING MULTICOLOR QUANTUM DOT TAGGED BEADS AND CONJUGATES THEREOF | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. (US) | 2004-04-21 | — | — | EP | claimed |
| US-20030148544-A1 | Methods of preparing multicolor quantum dot tagged beads and conjugates thereof | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. | 2003-08-07 | — | — | US | claimed |
| WO-2003003015-A2 | METHODS OF PREPARING MULTICOLOR QUANTUM DOT TAGGED BEADS AND CONJUGATES THEREOF | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| US-12011480-B2 | Nanoparticle compositions for sustained therapy | UTI LIMITED PARTNERSHIP (CA) | 2024-06-18 | — | — | US | disclosed |
| US-20230355730-A1 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES | UTI LIMITED PARTNERSHIP (CA) | 2023-11-09 | — | — | US | disclosed |
| US-20230193223-A1 | NUCLEOTIDE TRANSIENT BINDING FOR SEQUENCING METHODS | Life Technologies Corporation | 2023-06-22 | — | — | US | disclosed |
| CN-110354278-B | Methods and compositions for treating inflammation | UTI有限合伙公司 | 2023-05-02 | — | — | CN | disclosed |
| US-20220401534-A1 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | UTI LIMITED PARTNERSHIP (CA) | 2022-12-22 | — | — | US | disclosed |
| US-11447756-B2 | Nucleotide transient binding for sequencing methods | Life Technologies Corporation (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220211868-A1 | NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF | UTI LIMITED PARTNERSHIP (CA) | 2022-07-07 | — | — | US | disclosed |
| WO-2004054923-A1 | TERNARY AND QUATERNARY NANOCRYSTALS, PROCESSES FOR THEIR PRODUCTION AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2004-07-01 | — | — | WO | disclosed |
| US-6727065-B2 | Methods of use of semiconductor nanocrystal probes for treating a material | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-04-27 | — | — | US | disclosed |
| EP-1410031-A2 | METHODS OF PREPARING MULTICOLOR QUANTUM DOT TAGGED BEADS AND CONJUGATES THEREOF | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. (US) | 2004-04-21 | — | — | EP | disclosed |
| US-20030148544-A1 | Methods of preparing multicolor quantum dot tagged beads and conjugates thereof | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. | 2003-08-07 | — | — | US | disclosed |
| WO-2003040024-A2 | ASSAY BASED ON DOPED NANOPARTICLES | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003003015-A2 | METHODS OF PREPARING MULTICOLOR QUANTUM DOT TAGGED BEADS AND CONJUGATES THEREOF | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| US-6207392-B1 | COMPOUNDS CAPABLE OF LINKING TO ONE OR MORE RECEPTIVE MOLECULES; FOR THE DETECTION OF NUCLEOTIDE SEQUENCES; FOR THE RELEASE OF TOXIC COMPOUNDS IN TARGET CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401534-A1 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | CD47, TFRC, ICOS | CTSD 2799/4885KDM4E 1921/4885KDM5C 650/4885 |
| US-12011480-B2 | Nanoparticle compositions for sustained therapy | CD4, CD47, MALT1 | CTSD 2397/4885KDM4E 3815/4885KDM5C 3551/4885 |
| US-20220211868-A1 | NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF | MICA, CD74, HLA-C | CTSD 852/4885KDM4E 1939/4885KDM5C 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.